Danish precision-fermentation company 21st.Bio has submitted an EU regulatory dossier seeking approval for its recombinant beta-lactoglobulin protein, BLG+ Essential, for sale in the EU. The company is calling on EFSA to create a fast-track pathway for well-characterised nature-identical proteins.
Animal-free whey protein could eventually compete with dry whey in human food and some feed-adjacent markets, but commercial volumes are years away and the filing has no immediate effect on feed supply or prices.
Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.